Clinical Trial Update: Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating durvalumab in combination with chemotherapy and bevacizumab, followed by maintenance durvalumab, bevacizumab and olaparib in adv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Chemotherapy (undisclosed regimen)
• Durvalumab (durvalumab)
• Olaparib (Olaparib)

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Ovarian Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING